University of California Irvine

University of California Irvine was paid $153.06M by Medicaid between Jan 2018 and Dec 2024, across 879 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 13% of everything it billed.

33Billing provider infoUNIVERSITY OF CALIFORNIA IRVINE
ORANGE, CA 92868

33aNPI1689608150assigned 07/10/2006

33bProvider typeMulti-Specialty Clinic/Center

28Total paid$153.06M

24GClaims4,108,074

24DCodes billed879

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Multi-Specialty Clinic/Center providers in California

Rank by total paid#1 of 170

Median peer was paid$145K

This provider vs. median1,058×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	513,662	$14.78M
2019	466,997	$15.82M
2020	635,730	$21.04M
2021	680,130	$23.77M
2022	691,760	$24.55M
2023	661,156	$29.36M
2024incomplete	458,639	$23.74M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J9271	Injection, pembrolizumab, 1 mg	13%	9,622	3,285	$20.37M
J9299	Injection, nivolumab, 1 mg	4.7%	3,965	1,106	$7.23M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	4.4%	9,071	1,900	$6.79M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.4%	162,270	113,863	$6.70M
J9035	Injection, bevacizumab, 10 mg	3.5%	4,514	2,554	$5.37M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	3.0%	2,247	1,736	$4.57M
78815	Positron emission tomography (PET) for limited area imaging	2.9%	3,345	3,246	$4.37M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.5%	20,789	19,548	$3.84M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	1.9%	8,323	7,731	$2.95M
77386		1.8%	13,708	1,268	$2.77M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.5%	19,891	17,917	$2.34M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	1.5%	53,752	32,391	$2.22M

867 more codes

0760		1.4%	168,916	$2.12M
J0897	Injection, denosumab, 1 mg	1.4%	4,346	$2.11M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	34,962	$1.97M
J9306	Injection, pertuzumab, 1 mg	1.2%	3,056	$1.88M
J9312	Injection, rituximab, 10 mg	1.2%	1,467	$1.85M
J2505	Injection, pegfilgrastim, 6 mg	1.2%	1,578	$1.82M
0450	Emergency room services	1.2%	99,173	$1.80M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.2%	33,087	$1.78M
71275	Computed tomographic angiography, chest, with contrast material	<1%	7,884	$1.39M
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	1,868	$1.34M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	5,980	$1.26M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	8,540	$1.22M
96375	Therapeutic injection; each additional sequential IV push	<1%	39,188	$1.19M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	18,916	$1.14M
80053	Comprehensive metabolic panel	<1%	164,182	$1.12M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	5,320	$1.12M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	7,776	$1.12M
99284	Emergency room visit (serious)	<1%	6,673	$1.07M
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	1,441	$1.00M
G0378	Hospital observation service, per hour	<1%	3,680	$985K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	3,450	$828K
J0178	Injection, aflibercept, 1 mg	<1%	1,572	$798K
J3490	Unclassified drugs	<1%	184,272	$787K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	877	$770K
70450	Computed tomography, head or brain; without contrast material	<1%	14,827	$756K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	784	$753K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	156,154	$734K
93975		<1%	3,744	$701K
77301		<1%	868	$688K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	7,459	$686K
J9310	Injection, rituximab, 100 mg	<1%	396	$662K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	1,749	$645K
70498		<1%	4,576	$630K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	10,783	$625K
P9021	Red blood cells, each unit	<1%	4,770	$616K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	46,661	$609K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	14,845	$589K
96367		<1%	18,066	$562K
96415		<1%	13,331	$548K
0250		<1%	37,832	$547K
J0490	Injection, belimumab, 10 mg	<1%	479	$541K
Q5123	Injection, rituximab-arrx, biosimilar, (riabni), 10 mg	<1%	790	$531K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	30,423	$524K
77014		<1%	8,721	$517K
99283	Emergency room visit (moderate)	<1%	5,577	$511K
Q3014	Telehealth originating site facility fee	<1%	40,279	$505K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	5,457	$478K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	473	$475K
88185		<1%	2,738	$472K
99199	Unlisted special service, procedure or report	<1%	11,486	$466K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	11,702	$464K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,730	$462K
43259		<1%	1,532	$455K
0682		<1%	530	$449K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	9,492	$440K
96417		<1%	10,445	$415K
P9034	Platelets, pheresis, each unit	<1%	1,136	$412K
36430		<1%	6,814	$408K
93308		<1%	5,834	$399K
J0185	Injection, aprepitant, 1 mg	<1%	5,449	$374K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,556	$370K
71046	Radiologic examination, chest; 2 views	<1%	19,277	$366K
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	706	$361K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,609	$361K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	6,681	$347K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	278	$346K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	11,733	$345K
J9395	Injection, fulvestrant, 25 mg	<1%	938	$340K
93970		<1%	2,424	$331K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	11,139	$330K
70496		<1%	2,252	$329K
74183		<1%	1,788	$329K
J0485	Injection, belatacept, 1 mg	<1%	982	$320K
96361	Intravenous infusion, hydration; each additional hour	<1%	12,125	$319K
87497		<1%	8,538	$317K
0121		<1%	100	$304K
93971		<1%	3,589	$303K
72197		<1%	1,268	$303K
83735		<1%	66,193	$301K
71045	Radiologic examination, chest; single view	<1%	25,025	$294K
77334		<1%	2,020	$294K
Z7502		<1%	7,671	$292K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,084	$286K
0214		<1%	94	$284K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	9,012	$277K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,164	$274K
84443	Thyroid stimulating hormone (TSH)	<1%	26,661	$268K
59025	Fetal non-stress test	<1%	8,814	$267K
67028	Intravitreal injection of a pharmacologic agent	<1%	6,685	$267K
77412		<1%	4,884	$253K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	9,201	$248K
83880		<1%	12,178	$248K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	9,202	$247K
88341		<1%	3,435	$239K
77336		<1%	5,173	$237K
80197		<1%	19,937	$233K
74178		<1%	1,565	$226K
L0172	Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf	<1%	2,010	$224K
71250		<1%	3,472	$216K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,087	$209K
96416		<1%	3,267	$208K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	11,360	$204K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	11,117	$201K
84484		<1%	27,486	$200K
76604		<1%	6,033	$197K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,904	$192K
0270		<1%	87,569	$192K
80048	Basic metabolic panel (calcium, ionized)	<1%	34,283	$190K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	152	$190K
76830	Ultrasound, transvaginal	<1%	3,390	$187K
31237		<1%	859	$185K
81001		<1%	79,528	$180K
85027		<1%	36,527	$177K
77338		<1%	912	$177K
87631		<1%	3,774	$175K
0352		<1%	594	$172K
83036	Hemoglobin; glycosylated (A1C)	<1%	25,934	$172K
87799		<1%	6,347	$169K
80061	Lipid panel	<1%	18,143	$169K
84100		<1%	52,474	$168K
70486		<1%	1,862	$168K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	189	$163K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,835	$163K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	9,206	$162K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	26,762	$156K
70491		<1%	1,328	$149K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,047	$149K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	25,116	$143K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	1,936	$140K
J9228	Injection, ipilimumab, 1 mg	<1%	30	$139K
0300		<1%	13,448	$135K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,131	$132K
87086	Culture, bacterial; quantitative colony count, urine	<1%	25,046	$131K
91010		<1%	388	$130K
74174		<1%	612	$129K
83690		<1%	28,271	$126K
87536		<1%	2,136	$124K
97597		<1%	2,692	$124K
Z9725		<1%	2,828	$121K
86923		<1%	5,978	$121K
83605		<1%	17,028	$120K
85730		<1%	32,147	$117K
83970		<1%	4,232	$115K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,193	$114K
J2704	Injection, propofol, 10 mg	<1%	31,940	$113K
C1769	Guide wire	<1%	3,713	$113K
93017		<1%	3,089	$111K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	425	$108K
C8928	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report	<1%	464	$105K
0510		<1%	64,209	$104K
85610		<1%	43,893	$101K
95708		<1%	371	$100K
J7030	Infusion, normal saline solution , 1000 cc	<1%	33,072	$98K
77300		<1%	926	$97K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,301	$95K
97750		<1%	3,345	$93K
77290		<1%	719	$93K
76770		<1%	2,369	$92K
C1760	Closure device, vascular (implantable/insertable)	<1%	784	$91K
J9070	Cyclophosphamide, 100 mg	<1%	622	$91K
93325		<1%	1,698	$90K
52000		<1%	1,645	$89K
72131		<1%	1,556	$87K
73610		<1%	5,514	$87K
70543		<1%	470	$87K
0360		<1%	25,163	$86K
88307		<1%	1,178	$86K
73562		<1%	5,820	$84K
52310		<1%	316	$83K
J2777	Injection, faricimab-svoa, 0.1 mg	<1%	87	$82K
73130		<1%	4,998	$81K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	2,480	$81K
82378		<1%	7,531	$80K
J9267	Injection, paclitaxel, 1 mg	<1%	8,810	$80K
73630		<1%	5,312	$79K
0160		<1%	6,768	$79K
86803		<1%	7,247	$79K
59841		<1%	51	$78K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	996	$78K
V2632	Posterior chamber intraocular lens	<1%	1,371	$78K
86480		<1%	2,369	$78K
72157		<1%	492	$77K
86900		<1%	19,047	$76K
88342		<1%	4,712	$76K
88184		<1%	1,712	$75K
77080		<1%	1,138	$75K
J2353	Injection, octreotide, depot form for intramuscular injection, 1 mg	<1%	59	$75K
36591		<1%	17,351	$75K
82570		<1%	18,991	$74K
73030		<1%	5,121	$74K
86360		<1%	2,149	$73K
87077		<1%	13,769	$73K
83615		<1%	17,817	$73K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,159	$71K
72156		<1%	405	$70K
20610		<1%	2,445	$70K
77295		<1%	284	$69K
31231		<1%	2,077	$69K
0710		<1%	24,778	$68K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,575	$67K
90715		<1%	2,649	$65K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,610	$65K
72158		<1%	523	$65K
73110		<1%	4,152	$65K
49083		<1%	1,089	$64K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	13,388	$64K
84439		<1%	11,593	$63K
J7518	Mycophenolic acid, oral, 180 mg	<1%	1,144	$63K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	33,194	$63K
J2997	Injection, alteplase recombinant, 1 mg	<1%	1,051	$63K
86780		<1%	6,379	$63K
31575		<1%	2,638	$63K
82947		<1%	21,966	$62K
95700		<1%	391	$62K
84702		<1%	17,440	$61K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	456	$59K
86359		<1%	2,161	$59K
36415	Collection of venous blood by venipuncture	<1%	34,882	$59K
J1756	Injection, iron sucrose, 1 mg	<1%	5,102	$59K
36561		<1%	138	$58K
76981		<1%	1,010	$57K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	18,495	$57K
72128		<1%	919	$56K
97165		<1%	2,179	$56K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	34,392	$55K
76641		<1%	836	$55K
76536		<1%	1,722	$55K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	7,031	$54K
96402		<1%	4,127	$54K
73590		<1%	3,884	$53K
J9045	Injection, carboplatin, 50 mg	<1%	3,501	$52K
96411		<1%	2,154	$52K
73502		<1%	2,959	$52K
96523		<1%	7,565	$51K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	696	$51K
73552		<1%	2,995	$50K
84466		<1%	6,293	$50K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	762	$50K
J7050	Infusion, normal saline solution, 250 cc	<1%	23,098	$50K
Z7500		<1%	1,455	$49K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,070	$48K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	9,374	$48K
82728		<1%	8,423	$48K
86850		<1%	17,644	$47K
0011A		<1%	1,246	$47K
99213	Doctor's office visit, returning patient (routine)	<1%	2,477	$47K
72100		<1%	3,317	$46K
C1729	Catheter, drainage	<1%	3,655	$46K
92504		<1%	5,351	$45K
93880		<1%	563	$45K
77066	Tomosynthesis, mammo	<1%	568	$45K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,133	$44K
94060		<1%	956	$44K
92134		<1%	11,419	$44K
31579		<1%	728	$43K
73080		<1%	2,673	$43K
93798		<1%	1,867	$43K
74018		<1%	2,384	$43K
P9035	Platelets, pheresis, leukocytes reduced, each unit	<1%	91	$42K
93356		<1%	1,538	$42K
0012A		<1%	1,067	$41K
96376		<1%	1,593	$41K
86901		<1%	19,006	$41K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	111	$41K
50435		<1%	215	$41K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,722	$40K
87186		<1%	8,985	$39K
0370		<1%	7,618	$39K
0402		<1%	559	$38K
87070		<1%	7,712	$38K
C1726	Catheter, balloon dilatation, non-vascular	<1%	2,341	$38K
43235		<1%	212	$37K
88142		<1%	4,173	$37K
86140		<1%	10,650	$37K
93296		<1%	2,088	$36K
84156		<1%	12,965	$34K
C1788	Port, indwelling (implantable)	<1%	499	$33K
97010		<1%	3,813	$33K
87040		<1%	3,974	$33K
82043		<1%	7,968	$33K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	1,045	$33K
76377		<1%	1,808	$33K
J9190	Injection, fluorouracil, 500 mg	<1%	3,855	$32K
87088		<1%	6,889	$32K
36593		<1%	493	$32K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	36	$32K
38222		<1%	130	$32K
77370		<1%	418	$31K
87340		<1%	4,336	$31K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	5,548	$31K
86160		<1%	1,904	$30K
87081		<1%	8,463	$30K
82803		<1%	3,312	$29K
94729		<1%	1,482	$29K
85379		<1%	4,235	$29K
88313		<1%	932	$28K
82610		<1%	2,451	$28K
J1453	Injection, fosaprepitant, 1 mg	<1%	601	$28K
31622		<1%	158	$28K
73090		<1%	2,113	$28K
83540		<1%	6,752	$28K
J1644	Injection, heparin sodium, per 1000 units	<1%	8,265	$28K
86301		<1%	2,420	$27K
86255		<1%	2,666	$27K
86235		<1%	661	$27K
84550		<1%	8,957	$27K
78306		<1%	258	$27K
77065	Tomosynthesis, mammo	<1%	431	$26K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	27	$26K
0320		<1%	730	$26K
67228		<1%	343	$26K
76776		<1%	301	$26K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	32,041	$25K
72170		<1%	2,368	$25K
72141		<1%	313	$25K
0351		<1%	163	$25K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	29,849	$25K
97162		<1%	1,778	$25K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	3,180	$25K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	3,748	$24K
86304		<1%	2,871	$24K
92521		<1%	418	$24K
82105		<1%	1,982	$24K
73564		<1%	2,052	$24K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,362	$24K
87517		<1%	816	$24K
84403		<1%	1,538	$24K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	478	$24K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	6,068	$23K
93458		<1%	40	$23K
93321		<1%	1,469	$23K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	804	$23K
62323		<1%	184	$23K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	8,507	$23K
82784		<1%	3,575	$23K
76376		<1%	1,488	$23K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	1,439	$23K
81025		<1%	8,267	$22K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	<1%	45	$22K
84153		<1%	1,876	$22K
97602		<1%	853	$22K
73060		<1%	1,714	$21K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,543	$21K
85652		<1%	11,405	$21K
76512		<1%	1,123	$21K
86141		<1%	2,312	$21K
76998		<1%	266	$21K
86334		<1%	1,564	$20K
87808		<1%	2,295	$20K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,911	$20K
92202		<1%	2,187	$20K
77063	Screening digital breast tomosynthesis, bilateral	<1%	928	$20K
85018		<1%	13,917	$19K
69210		<1%	4,404	$19K
83521		<1%	1,647	$19K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,642	$19K
90677		<1%	329	$19K
73560		<1%	1,699	$18K
72040		<1%	1,269	$18K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	488	$18K
90686		<1%	1,759	$18K
82746		<1%	2,202	$18K
87205		<1%	7,614	$18K
0306		<1%	1,243	$18K
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,520	$17K
86704		<1%	2,042	$17K
92083		<1%	3,245	$17K
52356		<1%	30	$17K
82330		<1%	2,510	$17K
J7507	Tacrolimus, immediate release, oral, 1 mg	<1%	1,297	$17K
87522	Neg quan hep c or qual rna	<1%	534	$17K
64615		<1%	735	$17K
J9206	Injection, irinotecan, 20 mg	<1%	802	$16K
97799		<1%	3,157	$16K
76870		<1%	489	$16K
86706		<1%	2,205	$16K
L0130	Cervical, flexible, thermoplastic collar, molded to patient	<1%	290	$16K
93923		<1%	201	$16K
78816		<1%	12	$16K
0324		<1%	585	$16K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	5,126	$16K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	555	$15K
51798		<1%	2,207	$15K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	2,162	$15K
G0008	Administration of influenza virus vaccine	<1%	2,630	$15K
0002A		<1%	400	$15K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	229	$15K
94726		<1%	397	$15K
82274		<1%	1,207	$15K
73700		<1%	206	$15K
0001A		<1%	406	$15K
51700		<1%	804	$15K
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	307	$14K
80074		<1%	416	$14K
10060		<1%	647	$14K
82550		<1%	3,564	$14K
77280		<1%	208	$14K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	22,238	$14K
76937		<1%	1,185	$14K
82010		<1%	2,455	$14K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	270	$14K
76642		<1%	333	$14K
92133		<1%	3,809	$14K
76942		<1%	1,043	$14K
93350		<1%	245	$14K
0258		<1%	207	$13K
96409		<1%	445	$13K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17,166	$13K
94762		<1%	1,279	$13K
76000		<1%	757	$13K
80076		<1%	2,846	$13K
90632		<1%	235	$13K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	50	$13K
86762		<1%	1,069	$12K
97139		<1%	2,911	$12K
82607		<1%	4,546	$12K
97161		<1%	862	$12K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	8,505	$12K
88112		<1%	524	$12K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	807	$12K
43249		<1%	41	$12K
86038		<1%	1,428	$12K
J3489	Injection, zoledronic acid, 1 mg	<1%	688	$11K
96401		<1%	1,660	$11K
99499		<1%	192	$11K
90662		<1%	2,019	$11K
84165		<1%	1,836	$11K
97166		<1%	740	$11K
84402		<1%	647	$11K
92523		<1%	152	$11K
84270		<1%	782	$11K
87102		<1%	2,396	$11K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,842	$11K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,421	$11K
87184		<1%	2,678	$10K
82533		<1%	964	$10K
88173		<1%	486	$10K
92136		<1%	1,279	$10K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,300	$10K
20553		<1%	747	$10K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,288	$10K
90732		<1%	363	$10K
83516		<1%	1,178	$10K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,441	$10K
C9463	Injection, aprepitant, 1 mg	<1%	129	$10K
84478		<1%	3,313	$10K
0762		<1%	2,094	$10K
0350		<1%	300	$10K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	7,017	$9K
93925		<1%	102	$9K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,561	$9K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	6,382	$9K
74230		<1%	186	$9K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,398	$9K
0301		<1%	449	$9K
87206		<1%	2,836	$9K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	121	$9K
0420		<1%	229	$9K
82140		<1%	992	$8K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	13,057	$8K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	402	$8K
51702		<1%	920	$8K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,777	$8K
91122		<1%	27	$8K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	13	$8K
C1762	Connective tissue, human (includes fascia lata)	<1%	12	$8K
93990		<1%	114	$8K
Q5101	Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram	<1%	467	$8K
88312		<1%	471	$7K
0730		<1%	147	$7K
97802		<1%	83	$7K
85384		<1%	1,262	$7K
92250		<1%	1,211	$7K
0761		<1%	1,080	$7K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,088	$7K
96368		<1%	600	$7K
99153	Mod sedat endo service >5yrs	<1%	323	$7K
80180		<1%	750	$7K
88360		<1%	339	$7K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	301	$7K
99152		<1%	860	$7K
81003		<1%	4,153	$7K
77001		<1%	182	$7K
87075		<1%	1,555	$6K
77470		<1%	168	$6K
76380		<1%	74	$6K
0430		<1%	144	$6K
43242		<1%	27	$6K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,133	$6K
92226		<1%	833	$6K
0480		<1%	128	$6K
0949		<1%	845	$6K
90670		<1%	125	$6K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	1,616	$6K
86920		<1%	232	$6K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,693	$6K
16020		<1%	707	$6K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	108	$5K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	44	$5K
94010		<1%	330	$5K
11730		<1%	1,305	$5K
82248		<1%	1,493	$5K
72190		<1%	274	$5K
88304		<1%	766	$5K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	736	$5K
87015		<1%	1,646	$5K
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	732	$5K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	780	$5K
86200		<1%	684	$5K
92020		<1%	1,507	$5K
84145		<1%	330	$5K
0459		<1%	873	$5K
93041		<1%	1,648	$4K
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	<1%	1,033	$4K
64415		<1%	350	$4K
82150		<1%	1,227	$4K
73140		<1%	290	$4K
82670		<1%	188	$4K
74170		<1%	37	$4K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,065	$4K
J1815	Injection, insulin, per 5 units	<1%	6,193	$4K
86431		<1%	925	$4K
97116		<1%	1,298	$4K
J3480	Injection, potassium chloride, per 2 meq	<1%	2,098	$4K
88237		<1%	171	$4K
88177		<1%	221	$4K
J0456	Injection, azithromycin, 500 mg	<1%	509	$4K
87116		<1%	947	$4K
92025		<1%	1,324	$4K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	2,303	$4K
86355		<1%	133	$4K
36416		<1%	1,652	$4K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	290	$4K
96152		<1%	106	$4K
88108		<1%	545	$4K
86357		<1%	124	$4K
78264		<1%	17	$4K
G0009	Administration of pneumococcal vaccine	<1%	630	$4K
0064A		<1%	119	$3K
87581		<1%	112	$3K
66821		<1%	178	$3K
83883		<1%	563	$3K
87486		<1%	110	$3K
86800		<1%	305	$3K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	621	$3K
84132		<1%	2,196	$3K
76882		<1%	352	$3K
86833		<1%	136	$3K
86832		<1%	136	$3K
76775		<1%	80	$3K
71020		<1%	179	$3K
87147		<1%	1,017	$3K
62270		<1%	31	$3K
C1763	Connective tissue, non-human (includes synthetic)	<1%	42	$3K
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	<1%	1,338	$3K
77002		<1%	462	$3K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,060	$3K
88300		<1%	841	$3K
88172		<1%	325	$3K
94761		<1%	208	$3K
82977		<1%	559	$3K
11732		<1%	994	$3K
82565		<1%	1,545	$3K
88309		<1%	38	$3K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,354	$3K
Z7610		<1%	440	$3K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	3,143	$3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	<1%	16	$3K
82950		<1%	664	$3K
99234		<1%	3,715	$3K
84295		<1%	1,736	$3K
11056		<1%	1,155	$3K
93922		<1%	70	$3K
73200		<1%	27	$3K
72110		<1%	164	$3K
84146		<1%	262	$3K
88264		<1%	103	$3K
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	167	$2K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	402	$2K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	62	$2K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	367	$2K
88321		<1%	110	$2K
0004A		<1%	73	$2K
88720		<1%	457	$2K
87176		<1%	810	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	992	$2K
72082		<1%	94	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	98	$2K
82365		<1%	317	$2K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	301	$2K
99214	Doctor's office visit, returning patient (more involved)	<1%	44	$2K
93280		<1%	306	$2K
93297		<1%	123	$2K
74022		<1%	132	$2K
73000		<1%	151	$2K
64450		<1%	71	$2K
83520		<1%	281	$2K
J2060	Injection, lorazepam, 2 mg	<1%	3,322	$2K
77077		<1%	144	$2K
86147		<1%	67	$2K
51741		<1%	303	$2K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,376	$2K
0390		<1%	443	$2K
76857		<1%	123	$2K
85097		<1%	66	$2K
83001		<1%	165	$2K
C1781	Mesh (implantable)	<1%	12	$2K
84432		<1%	152	$2K
51728		<1%	15	$2K
82024		<1%	44	$2K
84520		<1%	1,350	$2K
J9394	Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg	<1%	33	$2K
95970		<1%	88	$2K
86300		<1%	116	$2K
J9370	Vincristine sulfate, 1 mg	<1%	316	$2K
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	478	$2K
92060		<1%	260	$2K
86256		<1%	180	$2K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	17	$2K
J9171	Injection, docetaxel, 1 mg	<1%	154	$2K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,162	$2K
36573		<1%	15	$2K
86769		<1%	132	$2K
82435		<1%	1,324	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	854	$2K
96150		<1%	55	$2K
80164		<1%	217	$2K
12002		<1%	173	$2K
84300		<1%	599	$2K
J7070	Infusion, d5w, 1000 cc	<1%	324	$2K
80158		<1%	117	$2K
88311		<1%	483	$2K
74246		<1%	24	$2K
95957		<1%	18	$2K
87106		<1%	280	$2K
85045		<1%	671	$2K
86870		<1%	14	$1K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	8,613	$1K
86376		<1%	129	$1K
72070		<1%	139	$1K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	33	$1K
88262		<1%	43	$1K
89051		<1%	1,794	$1K
43762		<1%	38	$1K
90750		<1%	69	$1K
85576		<1%	197	$1K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,796	$1K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	321	$1K
0071A		<1%	34	$1K
86592		<1%	396	$1K
J1940	Injection, furosemide, up to 20 mg	<1%	1,302	$1K
97003		<1%	157	$1K
12001		<1%	146	$1K
99497		<1%	61	$1K
11900		<1%	123	$1K
86039		<1%	147	$1K
A4649	Surgical supply; miscellaneous	<1%	29	$1K
11102		<1%	90	$1K
11100		<1%	26	$1K
88333		<1%	67	$1K
92611		<1%	39	$1K
77012		<1%	30	$1K
10005		<1%	14	$1K
70487		<1%	12	$1K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	384	$1K
0072A		<1%	28	$1K
96377		<1%	206	$1K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,446	$1K
87493		<1%	54	$1K
97535	Self-care/home management training, each 15 minutes	<1%	527	$1K
86593		<1%	287	$1K
87533		<1%	27	$1K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	555	$1K
84703		<1%	317	$983.05
99070		<1%	336	$968.58
36590		<1%	12	$967.05
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	122	$951.08
86644		<1%	78	$922.97
80177		<1%	238	$914.05
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	98	$893.68
J3535	Drug administered through a metered dose inhaler	<1%	285	$849.49
92612		<1%	12	$803.67
84157		<1%	493	$802.01
88334		<1%	49	$776.58
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	564	$745.11
J0461	Injection, atropine sulfate, 0.01 mg	<1%	303	$707.59
0346T		<1%	26	$707.41
86146		<1%	52	$706.03
95816		<1%	24	$702.92
L0140	Cervical, semi-rigid, adjustable (plastic collar)	<1%	13	$699.85
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	227	$689.92
51784		<1%	27	$677.99
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	24	$673.23
94727		<1%	64	$672.77
83002		<1%	66	$664.71
J1630	Injection, haloperidol, up to 5 mg	<1%	1,075	$661.90
88331		<1%	37	$659.44
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	270	$652.14
51797		<1%	27	$632.43
93246		<1%	298	$631.63
99201		<1%	12	$620.34
94799		<1%	167	$620.00
90656		<1%	40	$609.44
71010		<1%	57	$595.60
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	721	$588.32
86787		<1%	46	$587.76
A6258	Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	873	$585.87
12011		<1%	41	$585.27
S0164	Injection, pantoprazole sodium, 40 mg	<1%	174	$547.24
82945		<1%	298	$536.44
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	5,280	$531.70
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	455	$502.87
96549		<1%	214	$492.05
86922		<1%	16	$483.65
29125		<1%	80	$481.43
83935		<1%	160	$474.63
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	13	$456.29
92610		<1%	30	$435.68
31624		<1%	13	$435.30
77387		<1%	227	$432.76
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	1,168	$427.26
84681		<1%	31	$425.32
76001		<1%	28	$421.50
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	161	$416.40
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	1,555	$413.13
92225		<1%	29	$374.73
99221		<1%	14	$371.36
J2550	Injection, promethazine hcl, up to 50 mg	<1%	563	$370.97
90472	Immunization administration, each additional vaccine (list separately)	<1%	282	$367.03
93270		<1%	12	$364.00
85613		<1%	52	$351.66
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,157	$342.76
73522		<1%	26	$339.08
92522		<1%	28	$324.19
11721		<1%	909	$316.73
17110		<1%	119	$315.35
C1758	Catheter, ureteral	<1%	65	$309.81
93978		<1%	13	$293.01
36589		<1%	12	$288.54
77332		<1%	17	$280.70
95983		<1%	15	$261.66
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	<1%	164	$251.98
84480		<1%	26	$242.94
J1171	Injection, hydromorphone, 0.1 mg	<1%	34	$241.87
86430		<1%	73	$232.57
95836		<1%	27	$231.14
81015		<1%	178	$226.84
86317		<1%	41	$226.49
83930		<1%	57	$218.69
87400		<1%	94	$216.51
84425		<1%	40	$206.22
84155		<1%	137	$205.30
97163		<1%	25	$180.06
92201		<1%	13	$180.04
82787		<1%	27	$176.67
86753		<1%	16	$174.28
71101		<1%	12	$173.70
83655		<1%	30	$166.60
84481		<1%	14	$163.42
82247		<1%	33	$156.39
96127		<1%	12	$154.86
83010		<1%	15	$140.95
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	35	$132.51
85014		<1%	111	$132.43
85347		<1%	61	$125.51
86308		<1%	28	$118.12
G0127	Trimming of dystrophic nails, any number	<1%	13	$114.66
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	13	$110.25
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	52	$105.20
87045		<1%	13	$103.40
76514		<1%	110	$103.26
83550		<1%	28	$102.07
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	13	$99.66
20550		<1%	14	$96.52
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	51	$95.96
S0028	Injection, famotidine, 20 mg	<1%	5,239	$94.68
82962		<1%	129	$94.38
A6257	Transparent film, sterile, 16 sq. in. or less, each dressing	<1%	1,107	$88.76
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	12	$82.66
99001		<1%	247	$80.00
83006		<1%	14	$78.51
82042		<1%	59	$76.24
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	18	$70.67
J2590	Injection, oxytocin, up to 10 units	<1%	12	$67.86
86580		<1%	43	$67.82
84460		<1%	13	$64.74
81479	Unlisted molecular pathology procedure	<1%	29	$62.87
51736		<1%	15	$62.58
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	12	$61.52
87046		<1%	26	$60.91
82595		<1%	14	$60.29
84540		<1%	27	$48.61
J1953	Injection, levetiracetam, 10 mg	<1%	23	$48.23
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	304	$47.80
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	17	$42.50
51701		<1%	13	$42.00
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	12	$40.74
69209		<1%	17	$37.61
0272		<1%	891	$37.59
A6457	Tubular dressing with or without elastic, any width, per linear yard	<1%	14	$35.86
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	<1%	12	$33.96
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	46	$32.68
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	399	$25.84
82465		<1%	14	$25.52
S5010	5% dextrose and 0.45% normal saline, 1000 ml	<1%	426	$24.50
J2470	Injection, pantoprazole sodium, 40 mg	<1%	17	$24.21
81050		<1%	14	$23.64
83986		<1%	15	$19.57
A4217	Sterile water/saline, 500 ml	<1%	28	$15.98
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	32	$15.88
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	23	$10.88
A9150	Non-prescription drugs	<1%	174	$9.94
72050		<1%	14	$9.29
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	146	$7.88
11000		<1%	15	$6.00
A9270	Non-covered item or service	<1%	829	$4.42
20611		<1%	12	$3.38
J2730	Injection, pralidoxime chloride, up to 1 gm	<1%	12	$2.88
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	628	$1.59
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	571	$1.55
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	139	$0.69
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	134	$0.68
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	67	$0.59
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	135	$0.24
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	144	$0.24
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	227	$0.08
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	16	$0.05
0519		0%	221	$0.00
0611		0%	89	$0.00
0305		0%	103	$0.00
90480		0%	13	$0.00
0440		0%	22	$0.00
0610		0%	51	$0.00
0335		0%	687	$0.00
0310		0%	406	$0.00
0341		0%	21	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	49	$0.00
0780		0%	1,576	$0.00
3044F		0%	51	$0.00
0636		0%	4,468	$0.00
0482		0%	17	$0.00
0409		0%	14	$0.00
0612	Calcium glucon (wg critical)	0%	23	$0.00
0280		0%	66	$0.00
S0030	Injection, metronidazole, 500 mg	0%	162	$0.00
0349		0%	37	$0.00
0276		0%	17	$0.00
0481		0%	37	$0.00
99072		0%	282	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	91	$0.00
0489		0%	95	$0.00
0260		0%	560	$0.00
0278		0%	140	$0.00
0483		0%	62	$0.00
0311		0%	41	$0.00
0361		0%	49	$0.00
0920		0%	406	$0.00
0921		0%	22	$0.00
0750		0%	107	$0.00
0333		0%	209	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	73	$0.00
0343		0%	27	$0.00
0940		0%	94	$0.00
0460		0%	60	$0.00
0274		0%	21	$0.00
0623		0%	37	$0.00
91322		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIWABESSY, RANDOLPH (SR VP AND CFO)

Same official

Other billing entities under SIWABESSY, RANDOLPH

Full network →

Provider	Location	Paid
University of California Irvine	Lakewood, CA	$21.51M
University of California Irvine	Fountain Valley, CA	$16.83M
University of California Irvine	Placentia, CA	$6.87M
University of California Irvine	Los Alamitos, CA	$6.02M
Uc Regents	Fountain Valley, CA	$39K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.